BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang X, Amar S. p53 suppresses CCL2-induced subcutaneous tumor xenograft. Tumour Biol 2015;36:2801-8. [PMID: 25492482 DOI: 10.1007/s13277-014-2906-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang T, Zhan Q, Peng X, Qiu Z, Zhao T. CCL2 influences the sensitivity of lung cancer A549 cells to docetaxel. Oncol Lett 2018;16:1267-74. [PMID: 30061946 DOI: 10.3892/ol.2018.8769] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
2 Tang X, Aljahdali B, Alasiri M, Bamashmous A, Cao F, Dibart S, Salih E. A method for high transfection efficiency in THP-1 suspension cells without PMA treatment. Anal Biochem 2018;544:93-7. [PMID: 29305095 DOI: 10.1016/j.ab.2017.12.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Walton J, Blagih J, Ennis D, Leung E, Dowson S, Farquharson M, Tookman LA, Orange C, Athineos D, Mason S, Stevenson D, Blyth K, Strathdee D, Balkwill FR, Vousden K, Lockley M, McNeish IA. CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma. Cancer Res 2016;76:6118-29. [PMID: 27530326 DOI: 10.1158/0008-5472.CAN-16-1272] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 12.8] [Reference Citation Analysis]
4 San Román Gil M, Pozas J, Molina-Cerrillo J, Gómez J, Pian H, Pozas M, Carrato A, Grande E, Alonso-Gordoa T. Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy. Int J Mol Sci 2020;21:E4951. [PMID: 32668761 DOI: 10.3390/ijms21144951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]